array(52) {
  string(6) "Apache"
  string(22) "/product/extracta-dbs/"
  string(49) "/usr/local/sbin:/usr/local/bin:/usr/sbin:/usr/bin"
  string(48) "/var/www/vhosts/system/"
  string(19) "plesk-php74-fastcgi"
  string(10) "/index.php"
  string(0) ""
  string(3) "GET"
  string(8) "HTTP/1.1"
  string(7) "CGI/1.1"
  string(22) "/product/extracta-dbs/"
  string(5) "35474"
  string(48) "/var/www/vhosts/"
  string(14) "root@localhost"
  string(38) "/var/www/vhosts/"
  string(0) ""
  string(5) "https"
  string(38) "/var/www/vhosts/"
  string(13) ""
  string(3) "443"
  string(13) ""
  string(17) ""
  string(0) ""
  string(17) ""
  string(13) ""
  string(13) ""
  string(5) "close"
  string(5) "https"
  string(13) ""
  string(2) "US"
  string(40) "CCBot/2.0 ("
  string(63) "text/html,application/xhtml+xml,application/xml;q=0.9,*/*;q=0.8"
  string(14) "en-US,en;q=0.5"
  string(7) "br,gzip"
  string(17) ""
  string(2) "on"
  string(0) ""
  string(47) ""
  string(22) "/product/extracta-dbs/"
  string(27) "Y9oz6Sikrwd1wc8qNOPugQAAAAs"
  string(3) "200"
  string(17) ""
  string(2) "on"
  string(0) ""
  string(47) ""
  string(22) "/product/extracta-dbs/"
  string(27) "Y9oz6Sikrwd1wc8qNOPugQAAAAs"
  string(9) "RESPONDER"
  string(10) "/index.php"
  string(13) ""

Extracta DBS

PCR-ready genomic DNA from dried blood spots
Features & Benefits
  • Optimized for DNA extraction from dried blood spot punches
  • Single reagent for PCR-ready DNA in 30 minutes
  • Maximized assay sensitivity, lower Cq values, when combined with Quantabio ToughMix®
  • Compatible with high-throughput automation for PCR, qPCR and NGS applications


Extracta DBS is intended for molecular biology applications. This product is not intended for the diagnosis, prevention or treatment of a disease.

Kit Size
Order Info
Kit Size
Order Info
Extracta DBS
Request Sample
Kit Size:
Order Info:
1 x 10 mL
1 x 500 mL


Extracta DBS is a ready-to-use DNA extraction reagent for rapid and efficient recovery of PCR-ready DNA from dried blood spots (DBS) on Guthrie cards or Whatman 903 filter paper. This patented single-solution process produces DNA eluates that are substantially free of PCR inhibitors and compatible with a variety of end-point PCR, real-time PCR and Next Generation Sequencing (NGS) or Sanger Sequencing (1-3) reagents. Application of Extracta DBS with PerfeCTa® qPCR ToughMix or PerfeCTa MultiPlex qPCR ToughMix enables accurate and reproducible quantification of DNA sequences in blood using TaqMan® hydrolysis probe real-time qPCR.

Combine with ToughMix and maximize qPCR assay sensitivity

Extracta DBS is the perfect match with Quantabio ToughMix for sensitive and precise target quantification. The crude extraction combined with ToughMix, a Quantabio master mix that is tolerant to common PCR inhibitors, results in higher DNA yields independent of DNA sample inputs and qualities to enable accurate detection and high sensitivity even with low copy targets.

Reliable, Consistent Lot-to-Lot Performance

Low amounts and quality of DNA recovered from dried blood spots commonly restrict the utilization of DNA. To overcome these limitations, Extracta DBS increases the yield and quality allowing for efficient and reliable recovery of DNA from dried blood spots. Manufactured under stringent quality standards, Extracta DBS ensures uniform lot-to-lot performance resulting in reliable reproducibility in combination with Quantabio ToughMix.

Featured Publication

A Multiplexed Real-time PCR Assay to Detect SCID and SMN1 Homozygous Exon 7 Deletion, and A Droplet Digital PCR Assay to Assess SMN2 Copy Numbers, in Newborn screening for Spinal Muscular Atrophy

Download Featured Poster


What Customers Say

The simple and elegant way to unlock genetic information

Customer Profile Story

Co-Director of Newborn Screening
Mei Baker, MD, FACMG


Storage & Handling

Extracta DBS is stable for up to 2 years at 2-8°C. Please consult the product box label for expiration date information.

Customer Testimonials

Customer Testimonials

Extracta DBS

“The simple and elegant way to unlock genetic information”

Mei Baker, MD, FACMG | Co-Director of Newborn Screening - Wisconsin


Storage & Handling

Extracta DBS is stable for up to 2 years at 2-8°C. Please consult the product box label for expiration date information.

Performance Data


Customer Profile Stories

Product Manuals

Technical Notes

CofA (PSFs)



  • What is the shelf life of the Extracta DBS product?
    The shelf life is 2 years stored at 2-8°C.
  • What is the Extracta DBS kit and what are some of the advantages of using this kit?
    The Extracta DBS kit is a research use only reagent for rapid isolation of DNA from dried blood spots. It is supplied as a convenient “ready to use” solution that reduces sample preparation time and is compatible with automation. The numerous wash and/or proteolytic digestion steps of other protocols are not necessary with Extracta DBS and the eluted DNA solution does not interfere with downstream DNA amplification applications. Qiagen Beverly’s ISO13485 manufacturing process ensures consistent composition and performance across lots.
  • Should all of the supernatant be removed after the first wash and centrifugation step?
    After the first wash and centrifugation step, remove and discard as much liquid and debris as possible. The DNA remains on the filter paper at this point.
  • What Quantabio products have confirmed compatibility with DNA extracted by the Extracta DBS kit?
    The following Quantabio products have been demonstrated to perform well with the extracted DNA: Accustart Genotyping ToughMix (95115, 95116, 95117) PerfeCTa Multiplex qPCR ToughMix (95147, 95148, 95149) PerfeCTa qPCR ToughMix (95112, 95113, 95114, 95138, 95139, 95140)
  • For what downstream applications can the extracted DNA be used?
    The extracted DNA is compatible with a variety of end-point PCR, real-time PCR, next generation sequencing, or Sanger sequencing procedures.
  • Can the extracted DNA be stored?
    We recommend using the DNA in downstream applications immediately after extraction. If this is not possible, the extracted DNA can be refrigerated at 2-8°C for short term storage (1-2 days) or stored frozen at -15 to -25°C for prolonged storage. We have no data on the stability of extracted DNA after prolonged storage.
  • What is the stability of the extracted DNA?
    We have no data on the stability of the extracted DNA. We recommend that the DNA be used for downstream applications as soon as possible following extraction.
  • How should the extracted DNA be measured?
    Measurement of DNA by methods using DNA binding dyes or absorbance at 260 nm are not applicable to a crude lysis method such as the Extracta DBS method. The recommended way to accurately quantify DNA in an Extracta DBS lysate is to measure a specific DNA sequence (generally a single-copy gene in gDNA) by qPCR.
  • Click here to see all FAQs


    Sensitivity of Dried Blood Spot Testing for Detection of Congenital Cytomegalovirus Infection
    Sheila C. Dollard - 2021
    Importance The sensitivity of dried blood spots (DBS) to identify newborns with congenital cytomegalovirus (cCMV) infection has not been evaluated in screening studies using the current, higher-sensitivity methods for DBS processing. Objective To assess the sensitivity of DBS polymerase chain reaction (PCR) for newborn screening for cCMV infection using saliva as the reference standard for screening, followed by collection of a urine sample for confirmation of congenital infection. Design, Setting, and Participants This population-based cohort study took place at 5 newborn nurseries and 3 neonatal intensive care units in the Minneapolis/Saint Paul area in Minnesota from April 2016 to June 2019. Newborns enrolled with parental consent were screened for cCMV using DBS obtained for routine newborn screening and saliva collected 1 to 2 days after birth. Dried blood spots were tested for CMV DNA by PCR at both the University of Minnesota (UMN) and the US Centers for Disease Control and Prevention (CDC). Saliva swabs were tested by CMV DNA PCR at the UMN laboratory only. Newborns who screened positive by saliva or DBS had a diagnostic urine sample obtained by primary care professionals, tested by PCR within 3 weeks of birth. Analysis began July 2019. Exposures Detection of CMV from a saliva swab using a PCR assay. Main Outcomes and Measures Number of children with urine-confirmed cCMV and the proportion of them who were CMV positive through DBS screening. Results Of 12 554 individuals enrolled through June 2019 (of 25 000 projected enrollment), 56 newborns were confirmed to have cCMV (4.5 per 1000 [95% CI, 3.3-5.7]). Combined DBS results from either UMN or CDC had a sensitivity of 85.7% (48 of 56; 95% CI, 74.3%-92.6%), specificity of 100.0% (95% CI, 100.0%-100.0%), positive predictive value (PPV) of 98.0% (95% CI, 89.3%-99.6%), and negative predictive value (NPV) of 99.9% (95% CI, 99.9%-100.0%). Dried blood spot results from UMN had a sensitivity of 73.2% (95% CI, 60.4%-83.0%), specificity of 100.0% (100.0%-100.0%), PPV of 100.0% (95% CI, 91.4%-100.0%), and NPV of 99.9% (95% CI, 99.8%-99.9%). Dried blood spot results from CDC had a sensitivity of 76.8% (95% CI, 64.2%-85.9%), specificity of 100.0% (95% CI, 100.0%-100.0%), PPV of 97.7% (95% CI, 88.2%-99.6%), and NPV of 99.9% (95% CI, 99.8%-99.9%). Saliva swab results had a sensitivity of 92.9% (52 of 56; 95% CI, 83.0%-97.2%), specificity of 99.9% (95% CI, 99.9%-100.0%), PPV of 86.7% (95% CI, 75.8%-93.1%), and NPV of 100.0% (95% CI, 99.9%-100.0%). Conclusions and Relevance This study demonstrates relatively high analytical sensitivity for DBS compared with previous studies that performed population-based screening. As more sensitive DNA extraction and PCR methods continue to emerge, DBS-based testing should remain under investigation as a potential low-cost, high-throughput option for cCMV screening.
    Detection of Cytomegalovirus in Urine Dried on Filter Paper
    Minal M. Amin - 2021
    Urine is the best specimen for the diagnosis of congenital cytomegalovirus, but collection and processing of liquid urine are impractical for screening. Urine dried on filter paper was processed by the same convenient, low-cost method used by newborn screening to test blood spots and showed high sensitivity and specificity. To explore low cost, high-throughput methods to diagnose congenital cytomegalovirus infection (cCMV), we processed CMV-positive urine dried on filter paper by the same method used for processing blood spots for newborn screening. The results showed high sensitivity and specificity. Congenital cytomegalovirus (cCMV) infection is a leading cause of disability worldwide, occurring in approximately 0.4%–0.6% of live births [1]. There has been an increasing interest in universal newborn screening for cCMV due to the benefits of antiviral treatment and early intervention for hearing loss which improve outcomes. The best method for CMV screening remains unclear with saliva, urine, and dried blood spots (DBS) under investigation. Saliva and urine specimens both provide excellent sensitivity for diagnostic testing. Saliva swabs are convenient to collect, store, and transport. However, saliva testing lacks infrastructure for processing, and typically 8%–15% of positive results can be false-positive most likely from CMV in breast milk, requiring that saliva results are confirmed with urine testing [2–4]. DBS are already collected on nearly all newborns and show high specificity for CMV testing but to date have not shown adequate sensitivity. Urine testing offers better sensitivity and specificity than saliva and remains the gold standard specimen for diagnosing cCMV [4–6]. However, liquid urine is difficult to collect and, like saliva, has no infrastructure for large-scale testing. The present study examined whether urine dried on filter paper could be processed with the same streamlined procedures used for DBS in newborn screening.
    Newborn Screening for Severe Combined Immunodeficiency Using the Multiple of the Median Values of T-Cell Receptor Excision Circles
    Michael F. Cogley - 2021
    All newborn screening programs screen for severe combined immunodeficiency by measurement of T-cell receptor excision circles (TRECs). Herein, we report our experience of reporting TREC assay results as multiple of the median (MoM) rather than using conventional copy numbers. This modification simplifies the assay by eliminating the need for standards with known TREC copy numbers. Furthermore, since MoM is a measure of how far an individual test result deviates from the median, it allows normalization of TREC assay data from different laboratories, so that individual test results can be compared regardless of the particular method, assay, or reagents used.
    Assessing the Performance of Dried-Blood-Spot DNA Extraction Methods in Next Generation Sequencing
    Miyono Hendrix - 2020
    An increasing number of newborn screening laboratories in the United States and abroad are moving towards incorporating next-generation sequencing technology, or NGS, into routine screening, particularly for cystic fibrosis. As more programs utilize this technology for both cystic fibrosis and beyond, it is critical to identify appropriate DNA extraction methods that can be used with dried blood spots that will result in consistent, high-quality sequencing results. To provide comprehensive quality assurance and technical assistance to newborn screening laboratories wishing to incorporate NGS assays, CDC’s Newborn Screening and Molecular Biology Branch designed a study to evaluate the performance of nine commercial or laboratory-developed DNA extraction methods that range from a highly purified column extraction to a crude detergent-based no-wash boil prep. The DNA from these nine methods was used in two NGS library preparations that interrogate the CFTR gene. All DNA extraction methods including the cruder preps performed reasonably well with both library preps. One lower-concentration, older sample was excluded from one of the assay evaluations due to poor performance across all DNA extraction methods. When 84 samples, versus eight, were run on a flow cell, the DNA quality and quantity were more significant variables.

    Customer Testimonials

    Extracta DBS

    “The simple and elegant way to unlock genetic information”

    Mei Baker, MD, FACMG | Co-Director of Newborn Screening - Wisconsin

    Product Finder

    Select Your Assay

    Starting Template

    Assay Format

    Detection Chemistry

    Multiplexing (more than 3 targets)

    Is gene-specific priming (GSP) required?

    What current Reverse Transcriptase or cDNA kit are you using?

    Select the group which contains your real-time PCR cycler

    • Applied Biosystems 7500
    • Applied Biosystems 7500 Fast
    • Stratagene Mx3000P®
    • Stratagene Mx3005P™
    • Stratagene Mx4000™
    • Applied Biosystems ViiA 7
    • Applied Biosystems QuantStudio™
    • Agilent AriaMx
    • Douglas Scientific IntelliQube®
    • Applied Biosystems 5700
    • Applied Biosystems 7000
    • Applied Biosystems 7300
    • Applied Biosystems 7700
    • Applied Biosystems 7900
    • Applied Biosystems 7900HT
    • Applied Biosystems 7900 HT Fast
    • Applied Biosystems StepOne™
    • Applied Biosystems StepOnePlus™
    • Quantabio Q
    • BioRad CFX
    • Roche LightCycler 480
    • QIAGEN Rotor-Gene Q
    • Other
    • BioRad iCycler iQ™
    • BioRad MyiQ™
    • BioRad iQ™5

    Choose your application from the categories below


    I give Quantabio or an authorized Quantabio distributor permission to contact me for product updates and news.
    * Required information